Václava Polívková

Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission

Kateřina Machová Poláková, Hana Žižková, Jan Zuna et al. · Leukemia · 2020 · 30 citations · Full text

Medicine, Molecular Biology, Oncology +15

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment

Monika Jaruskova, Nikola Čuřík, Rajna Hercog et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 27 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Constant BCR-ABL transcript level ≥0.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis

Kateřina Machová Poláková, Václava Polívková, Jana Rulcová et al. · Experimental Hematology · 2009 · 22 citations

Life Sciences, Hematology, Molecular Biology +13

Tumor markers in pleural effusions.

Ondřej Topolčan, L Holubec, Václava Polívková et al. · PubMed · 2007 · 22 citations

Medicine, Oncology, Pathology +17

Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients

Václava Polívková, Peter Rohoň, Hana Klamová et al. · PLoS ONE · 2016 · 22 citations · Full text

Life Sciences, Hematology, Immunology +14